BIZM Key Stats
- SA PRO: Top Long And Short Ideas, Monday December 30 12/31 07:30 ET
- BIOZOOM, INC. Files SEC form 10-Q, Quarterly Report 08/19 17:23 ET
- SEC Freezes Argentine Citizens’ Assets Over Biozoom Share Sales 07/03 13:44 ET
- BIOZOOM, INC. Files SEC form 10-K/A, Annual Report 07/02 09:56 ET
- BIOZOOM, INC. Files SEC form 10-K, Annual Report 07/02 09:25 ET
- Biozoom: Current Shareholders Likely Victims Of An Illegal Stock Promotion Scam 06/24 08:35 ET
- Biozoom Enters Into Commercial Phase of Scanner Production PR Newswire 06/24 07:13 ET
- SA Pro Insider's Report, Friday June 21 06/22 07:45 ET
- A $234 Million Company Worth $0: Short Biozoom 06/21 06:30 ET
- BIOZOOM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits 06/20 09:50 ET
BIZM Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biozoom is down 98.82% over the last year vs S&P 500 Total Return up 24.21%, Abiomed up 75.99%, and Solei Systems down 93.33%.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for BIZM
Pro Strategies Featuring BIZM
Did Biozoom make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Medical Devices
- Headquarters Country: Germany
- Headquarters State/Province: N/A
- Incorporation Country: N/A
- Incorporation State/Province: N/A
Biozoom Inc holds certain patents and licenses to technology in the field of devices that use spectroscopics to detect and measure substances within the body or other biological substances.